GlassScriptPhysician profile
Melissa C Bradley
NPI 1821292590
$3,687.01
in general payments reported to CMS, 2019-2025
33 companies · $586 in 2025
The $586 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $265 · 2021: $434 · 2022: $609 · 2023: $625 · 2024: $737 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,848 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,848.40 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $582.05 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $359.21 | 2023-2025 | Myfembree |
| Organon LLC | $298.51 | 2022-2025 | Jada System, Nexplanon |
| Astellas Pharma US INC | $263.86 | 2021-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $261.40 | 2019-2022 | |
| Biogen, INC. | $212.87 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $194.52 | 2022-2025 | Novasure, Acessa Provu System, Aptima |
| Myovant Sciences INC. | $194.12 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $180.75 | 2019-2025 | Gardasil 9, Gardasil |
| Mayne Pharma Commercial LLC | $118.70 | 2021-2024 | |
| Exeltis, USA INC. | $110.10 | 2020-2025 | Slynd |
| Avanos Medical | $108.80 | 2019-2023 | On-Q* Pump and Accessories |
| Bayer Healthcare Pharmaceuticals INC. | $97.05 | 2019-2022 | |
| Ethicon US, LLC | $91.59 | 2023-2024 | Vistaseal, Dermabond Prineo, Ethicon |
| Pacira Pharmaceuticals Incorporated | $77.56 | 2023-2024 | Exparel, Iovera |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $66.68 | 2024-2025 | |
| Allergan, INC. | $65.31 | 2019 | |
| Myriad Women'S Health, INC. | $48.20 | 2023 | Myrisk |
| Baxter Healthcare | $39.17 | 2024-2025 | Perclot |
| Coloplast Corp | $35.14 | 2020-2023 | Altis |
| Channel Medsystems, INC. | $33.32 | 2022 | |
| Scynexis, INC. | $32.85 | 2022 | |
| Pharmacosmos Therapeutics INC. | $32.18 | 2022 | |
| Millicent US INC | $26.52 | 2020-2025 | Intrarosa, Femlyv |
| Momentis Surgical INC. | $26.00 | 2022 | |
| Daiichi Sankyo INC. | $19.88 | 2020 | |
| Agile Therapeutics, INC. | $18.25 | 2022 | |
| Avion Pharmaceuticals | $17.72 | 2020 | |
| Exact Sciences Corporation | $16.03 | 2025 | The Cologuard Plus Collection Kit |
| Amag Pharmaceuticals, INC. | $15.90 | 2019 | |
| Minerva Surgical, INC | $15.60 | 2019 | |
| Optumhealth Care Solutions, LLC | $14.41 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Boston Scientific Corporation | $12.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.